glp-1 class action Ozempic® Lawsuit GLP-1 Agonists - What is
Description
S., Tucker, J

Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Last June 26, 2023, a phase 2 trial was conducted with participants having a BMI of 30 or higher or BMI of 27 to less than 30 with weight-related conditions

10.1089/dia.2025.8818.sg 36 GhusnW.HurtadoM

Each study was assessed across key domains, including clarity of objectives, eligibility criteria, sample size justification, outcome measurement, blinding (if applicable), and adequacy of statistical analyses

This probiotic supplement aims to support a balanced gut microbiome, enhance digestion, and alleviate common digestive issues like bloating and constipation
